Table 2.

Univariate survival analysis.

		FPS (progression-free survival)		P value a
Variables	All cases	Median (SE)	95% CI
Expression				0.000
High	57	15(1.029)	12.982~17.018
Low	51	21(2.550)	16.002~25.998
Age b				0.064
≤50	75	18(1.176)	15.695~20.305
>50	33	14(1.595)	10.874~17.126
WHO grade				0.030
G1	49	20(1.500)	17.061~22.939
G2	38	14(1.761)	10.548~17.452
G3	21	13(1.907)	9.262~16.738
T status				0.161
T2	37	17(2.021)	13.039~20.961
T3	45	16(1.341)	13.371~18.629
T4	26	17(1.530)	14.002~19.998
N				0.032
N0	71	18(1.684)	14.700~21.300
N1	37	16(0.995)	14.049~17.951
M				0.031
M0	82	18(1.727)	14.614~21.386
M1	26	16(1.291)	13.470~18.530
FIGO stage				0.239
II	32	17(2.258)	12.574~21.426
III	42	16(1.573)	12.917~19.083
IV	34	17(1.200)	14.648~19.352
CRT response				0.047
CR	46	20(1.884)	16.307~23.693
Non-CR	62	15(1.181)	12.685~17.315

^a Log-rank test; ^b Median age; CI: confidence interval; P: P value;

T status: T stages; N status: lymph nodes status; M status: Distant metastasis;

CR: Complete response/ complete remission; CRT: chemoradiotherapy;